Five years after a stern warning from Bill Gates and other business leaders, U.S. funding for energy R&D remains stuck in the mud.
Scientific advances and new business models are spurring investor confidence in biomedical-related ventures.
The Keystone XL pipeline is a distraction from what's really needed to solve climate change.
The chemical company BASF says the basic type of battery used now in hybrids could be improved tenfold, leading to cheaper electric cars.
The world’s largest and cheapest reverse-osmosis desalination plant is up and running in Israel.
A global network of millions of genomes could be medicine’s next great advance.
Availability: 1-2 years
A new method for growing human brain cells could unlock the mysteries of dementia, mental illness, and other neurological disorders.
Fast DNA-sequencing machines are leading to simple blood tests for cancer.
A new mathematical model of the way the disease spreads in West Africa predicts that the Ebola epidemic should be over by the middle of the spring.
The cost of solar has fallen to a point where it can compete with grid power in some places.